Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-03-08
1991-05-21
Kepplinger, Esther L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 514 21, 530381, 530380, 530382, 530383, 530384, 530395, 530359, 530422, 530424, 530829, 530830, A61K 3702, A61K 3704, C07K 1516
Patent
active
050175564
ABSTRACT:
A method and therapeutic composition for the treatment of bleeding disorders, for example those characterized by a tendency toward hemorrhage or a hypercoagulative state, by the administration of tissue factor protein or antagonists thereof.
REFERENCES:
patent: 2516216 (1950-07-01), Kazal et al.
patent: 2847350 (1958-08-01), Singher
patent: 3980432 (1976-09-01), Trobisch et al.
patent: 4416812 (1983-11-01), Becker et al.
Rao et al., Anal. Biochem. 165:365-370 (1987).
Bom et al., Thromb. Res. 42:635-643 (1986).
Guha et al., Proc. Natl. Acad. Sci. U.S.A. 83:299-302 (1986).
Carson et al., Science 229:991-993 (1985).
Carson, FEBS Letters 132(1):37-40 (1981).
Osterud, Scand. J. Haematol., 32:337-345 (1984).
Giercksky et al., Scand. J. Haematol., 16:300-310 (1976).
Lewis et al., J. Lab & Clin. Med. 60(2):261-273 (1962).
Gollub et al., Thromb. Diath. Haemorh. 7:470-479 (1962).
Osterud, Biochem. Biophys. Res. Comm. 88(1):59-67 (1979).
Carson et al., Blood 66(1):152-156 (1985).
Gonmori et al., Biblio. Haematol., 49:23-39 (1983).
Ewan et al., J. Immunol. 136(7):2408-2415 (1986).
Morrissey et al., 59th Sci. Sessions (Nov. 19, 1986) American Heart Assoc. (Oral Presentation, Notes Attached).
Bach et al., 59th Sci. Sessions (Nov. 19, 1986) American Heart Assoc. (Oral Presentation, Notes Attached).
The U.S. Pharmacopeia (Rev. 21), Section 1211: pp. 1347-1493, Jan. 1, 1985.
The U.S. Pharmacopeia (Rev. 21), Section 1151: pp. 1338-1339, Jan. 1, 1985.
Bach et al., J. Biol. Chem., 256(16), 8324-31, (1981).
Broze et al., J. Biol. Chem., 260(20), 10917-20, (1985).
Bjorklind et al., Biochem. J., 165, 89-96, (1977).
Freyssinet et al., Thromb. Haemostasis, 55(1), 112-18, (1986).
Tanaka et al., Thromb. Res., 40(6), 745-56, (Dec. 1985).
Osterud, Scand. J. Haemotol., 32, 337-45, (1984).
Kurosawa et al., Thromb. Res., 33, 595-606, (1984).
Carlson et al., Thromb Haemostasis, 48(3), 315-19, (1982).
O'Brien Donogh P.
Vehar Gordon A.
Genentech Inc.
Hensley Max D.
Kepplinger Esther L.
Kushan Jeff
Winter Daryl B.
LandOfFree
Treatment of bleeding disorders using lipid-free tissue factor p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of bleeding disorders using lipid-free tissue factor p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of bleeding disorders using lipid-free tissue factor p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-238478